Sarcopenia Program

About Allosteric Bioscience

Allosteric Bioscience is an early-stage, private biotech leveraging computational and AI-driven methods to discover allosteric modulators for CNS disorders. The company has licensed a sarcopenia (muscle loss) prevention/treatment technology from Johns Hopkins University, indicating an expansion beyond its core neurological focus. Its positioning at the convergence of quantum computing and biology suggests a highly ambitious, platform-based strategy, though the company appears to be in a pre-clinical or discovery stage with no disclosed pipeline candidates.

Therapeutic Areas